Foster-Cheek Kaye I — SEC Form 4 filings
SEC reporting owner CIK 1312622. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-07 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 6,000 shares, $191,531 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 4,415 shares @ $31.99 ($141,236) in AGIOS PHARMACEUTICALS, INC., filed 2024-03-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | 6 | — | 3 legs · 6,000 sh · $191,531 | 13 |
| Prime Medicine, Inc. (PRME) | Director | 4 | — | — | 11 |
Form 4 filings — Foster-Cheek Kaye I
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,816 @ $0 · Option exercise (M): 2,816 (derivative) @ $0 · Grant/award (A): 2,927 (derivative) @ $0 · Grant/award (A): 14,950 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-08-05 | 4 | Prime Medicine, Inc. (PRME) | Disposition to issuer (D): 13,510 (derivative) · Grant/award (A): 13,510 (derivative) · Disposition to issuer (D): 9,006 (derivative) · Grant/award (A): 9,006 (derivative) · Disposition to issuer (D): 39,062 (derivative) · Grant/award (A): 39,062 (derivative) · +2 more | EDGAR |
| 2025-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,120 @ $0 · Grant/award (A): 2,816 (derivative) @ $0 · Grant/award (A): 15,768 (derivative) @ $0 · Option exercise (M): 2,120 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/award (A): 2,120 (derivative) @ $0 · Grant/award (A): 11,774 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 3,388 @ $0 · Gift (G): 3,564 @ $0 · Option exercise (M): 3,388 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale (S): 1,285 @ $31.62 | EDGAR |
| 2024-03-07 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale (S): 300 @ $32.21 · Sale (S): 4,415 @ $31.99 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1312622 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →